Bolt Book Value Per Share from 2010 to 2024

BOLT Stock

USD 0.60 0.02 3.45%

Bolt Biotherapeutics Book Value Per Share yearly trend continues to be comparatively stable with very little volatility. Book Value Per Share is likely to outpace its year average in 2024. Book Value Per Share is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of Bolt Biotherapeutics according to its financial statements. View All Fundamentals

Book Value Per Share

First Reported

2010-12-31

Previous Quarter

2.98162085

Current Value

3.13

Quarterly Volatility

2.92873538

Credit Downgrade

Yuan Drop

Covid

Check Bolt Biotherapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bolt Biotherapeutics' main balance sheet or income statement drivers, such as Net Interest Income of 6.5 M, Interest Income of 6.5 M or Depreciation And Amortization of 2.5 M, as well as many indicators such as Price To Sales Ratio of 5.11, Dividend Yield of 0.0 or PTB Ratio of 0.39. Bolt financial statements analysis is a perfect complement when working with Bolt Biotherapeutics Valuation or Volatility modules.

Check out the analysis of Bolt Biotherapeutics Correlation against competitors.

For more information on how to buy Bolt Stock please use our How to Invest in Bolt Biotherapeutics guide.

Latest Bolt Biotherapeutics' Book Value Per Share Growth Pattern

Below is the plot of the Book Value Per Share of Bolt Biotherapeutics over the last few years. It is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements. Bolt Biotherapeutics' Book Value Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bolt Biotherapeutics' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 2.96 X

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Book Value Per Share

Timeline

Bolt Book Value Per Share Regression Statistics

	Arithmetic Mean	(0.14)
	Coefficient Of Variation	(2,148)
	Mean Deviation	2.39
	Median	(1.69)
	Standard Deviation	2.93
	Sample Variance	8.58
	Range	9.5831
	R-Value	0.68
	Mean Square Error	5.02
	R-Squared	0.46
	Significance	0.01
	Slope	0.44
	Total Sum of Squares	120.08

Bolt Book Value Per Share History

	2024	3.13
	2023	2.98
	2022	4.59
	2021	6.69
	2020	-2.9
	2019	-1.31

Other Fundumenentals of Bolt Biotherapeutics

Tangible Book Value Per Share

Bolt Biotherapeutics Book Value Per Share component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Total Liab	Net Invested Capital	Total Current Assets	Net Working Capital	Short Term Debt	Property Plant Equipment	Current Deferred Revenue	Net Receivables	Deferred Long Term Liab	Common Stock
Total Assets		0.93	0.9	0.68	-0.81	0.95	0.2	0.93	0.99	0.99	0.87	0.91	0.95	0.45	-0.33	0.59
Total Stockholder Equity	0.93		0.93	0.55	-0.7	0.83	-0.16	1.0	0.94	0.95	0.69	0.76	0.82	0.46	-0.26	0.54
Net Tangible Assets	0.9	0.93		0.67	-0.86	0.85	-0.12	0.93	0.9	0.9	0.76	0.81	0.87	0.71	-0.58	0.73
Net Debt	0.68	0.55	0.67		-0.89	0.73	0.34	0.55	0.7	0.68	0.75	0.8	0.81	0.66	-0.57	0.83
Retained Earnings	-0.81	-0.7	-0.86	-0.89		-0.89	-0.25	-0.7	-0.82	-0.8	-0.9	-0.91	-0.88	-0.84	0.72	-0.92
Accounts Payable	0.95	0.83	0.85	0.73	-0.89		0.34	0.83	0.96	0.95	0.96	0.97	0.92	0.56	-0.42	0.71
Total Liab	0.2	-0.16	-0.12	0.34	-0.25	0.34		-0.16	0.17	0.13	0.5	0.42	0.34	-0.12	-0.05	0.06
Net Invested Capital	0.93	1.0	0.93	0.55	-0.7	0.83	-0.16		0.94	0.95	0.69	0.76	0.82	0.46	-0.26	0.54
Total Current Assets	0.99	0.94	0.9	0.7	-0.82	0.96	0.17	0.94		1.0	0.87	0.91	0.92	0.48	-0.32	0.64
Net Working Capital	0.99	0.95	0.9	0.68	-0.8	0.95	0.13	0.95	1.0		0.84	0.89	0.91	0.46	-0.3	0.62
Short Term Debt	0.87	0.69	0.76	0.75	-0.9	0.96	0.5	0.69	0.87	0.84		0.99	0.91	0.58	-0.48	0.71
Property Plant Equipment	0.91	0.76	0.81	0.8	-0.91	0.97	0.42	0.76	0.91	0.89	0.99		0.95	0.57	-0.43	0.71
Current Deferred Revenue	0.95	0.82	0.87	0.81	-0.88	0.92	0.34	0.82	0.92	0.91	0.91	0.95		0.51	-0.47	0.64
Net Receivables	0.45	0.46	0.71	0.66	-0.84	0.56	-0.12	0.46	0.48	0.46	0.58	0.57	0.51		-0.87	0.94
Deferred Long Term Liab	-0.33	-0.26	-0.58	-0.57	0.72	-0.42	-0.05	-0.26	-0.32	-0.3	-0.48	-0.43	-0.47	-0.87		-0.74
Common Stock	0.59	0.54	0.73	0.83	-0.92	0.71	0.06	0.54	0.64	0.62	0.71	0.71	0.64	0.94	-0.74

Click cells to compare fundamentals

About Bolt Biotherapeutics Financial Statements

Bolt Biotherapeutics shareholders use historical fundamental indicators, such as Book Value Per Share, to determine how well the company is positioned to perform in the future. Although Bolt Biotherapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in Bolt Biotherapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Bolt Biotherapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Book Value Per Share	2.98	3.13
Tangible Book Value Per Share	2.98	3.13

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Bolt Stock Analysis

When running Bolt Biotherapeutics' price analysis, check to measure Bolt Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bolt Biotherapeutics is operating at the current time. Most of Bolt Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Bolt Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bolt Biotherapeutics' price. Additionally, you may evaluate how the addition of Bolt Biotherapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC